{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T21:33:05Z","timestamp":1793309585933,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.jpba.2026.117747","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:17:58Z","timestamp":1790291878000},"page":"117747","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["An integrated analytical workflow for characterizing insoluble matter in traditional Chinese medicine injections: Danshen and Guanxinning injections as case studies"],"prefix":"10.1016","volume":"283","author":[{"given":"Le","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9877-4316","authenticated-orcid":false,"given":"Haibin","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2026.117747_bib1","unstructured":"U.S. Pharmacopeial Convention, \u3008788\u3009 particulate matter in injections, in: United States Pharmacopeia and National Formulary (USP\u2013NF), USP, Rockville, MD, 2024."},{"key":"10.1016\/j.jpba.2026.117747_bib2","unstructured":"U.S. Pharmacopeial Convention, \u3008790\u3009 visible particulates in injections, in: United States Pharmacopeia and National Formulary (USP\u2013NF), USP, Rockville, MD, 2024."},{"key":"10.1016\/j.jpba.2026.117747_bib3","unstructured":"U.S. Food and Drug Administration, Inspection of Injectable Products for Visible Particulates: Draft Guidance for Industry, FDA, 2021."},{"key":"10.1016\/j.jpba.2026.117747_bib4","series-title":"Particulate Contamination: Sub-visible Particles, in: European Pharmacopoeia","author":"Council of Europe, Chapter 2.9.19","year":"2023"},{"key":"10.1016\/j.jpba.2026.117747_bib5","unstructured":"International Council for Harmonisation, ICH Q9(R1): Quality Risk Management, ICH, 2023."},{"key":"10.1016\/j.jpba.2026.117747_bib6","series-title":"ICH Q2(R2): Validation of Analytical Procedures","author":"International Council for Harmonisation","year":"2023"},{"key":"10.1016\/j.jpba.2026.117747_bib7","doi-asserted-by":"crossref","first-page":"186","DOI":"10.5731\/pdajpst.2013.00922","article-title":"Particulate matter in injectable drug products","volume":"67","author":"Langille","year":"2013","journal-title":"PDA J. Pharm. Sci. Technol."},{"key":"10.1016\/j.jpba.2026.117747_bib8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.5731\/pdajpst.2015.01037","article-title":"Industry perspective on the medical risk of visible particles in injectable drug products","volume":"69","author":"Bukofzer","year":"2015","journal-title":"PDA J. Pharm. Sci. Technol."},{"key":"10.1016\/j.jpba.2026.117747_bib9","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2174\/138920109788488905","article-title":"A critical review of analytical methods for subvisible and visible particles","volume":"10","author":"Narhi","year":"2009","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.jpba.2026.117747_bib10","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1002\/jps.21530","article-title":"Overlooking subvisible particles in therapeutic protein products: gaps that may compromise product quality","volume":"98","author":"Carpenter","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2026.117747_bib11","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1002\/jps.21566","article-title":"Protein aggregation: pathways, induction factors and analysis","volume":"98","author":"Mahler","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2026.117747_bib12","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1208\/s12248-010-9205-1","article-title":"M. Sukumar, Micro-flow imaging: flow microscopy applied to sub-visible particulate analysis in protein formulations","volume":"12","author":"Sharma","year":"2010","journal-title":"AAPS J."},{"key":"10.1016\/j.jpba.2026.117747_bib13","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1002\/jps.21719","article-title":"Silicone oil- and agitation-induced aggregation of a monoclonal antibody in aqueous solution","volume":"98","author":"Thirumangalathu","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2026.117747_bib14","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1208\/s12249-010-9506-9","article-title":"Factors affecting the chemical durability of glass used in the pharmaceutical industry","volume":"11","author":"Iacocca","year":"2010","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jpba.2026.117747_bib15","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1208\/s12249-014-0167-y","article-title":"Glass delamination: a comparison of the inner surface performance of vials and pre-filled syringes","volume":"15","author":"Zhao","year":"2014","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jpba.2026.117747_bib16","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1002\/jps.23552","article-title":"Micro-flow imaging and resonant mass measurement (Archimedes): complementary methods to quantitatively differentiate protein particles and silicone oil droplets","volume":"102","author":"Weinbuch","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2026.117747_bib17","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jpba.2017.10.015","article-title":"Forensic investigation in the pharmaceutical industry: identification procedure of visible particles in (drug) solutions and different containers by combining vibrational and X-ray spectroscopic techniques","volume":"148","author":"Hindelang","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117747_bib18","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s13020-022-00681-w","article-title":"Traditional Chinese medicine injections: where we are after 80-year development","volume":"17","author":"Zheng","year":"2022","journal-title":"Chin. Med."},{"key":"10.1016\/j.jpba.2026.117747_bib19","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/bcp.12598","article-title":"An overview on adverse drug reactions to traditional Chinese medicines","volume":"80","author":"Chan","year":"2015","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jpba.2026.117747_bib20","article-title":"Safety of using traditional Chinese medicine injections in primary medical institutions: based on the spontaneous reporting system 2016\u20132020 in Henan Province, China","volume":"13","author":"Yan","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jpba.2026.117747_bib21","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.apsb.2017.11.002","article-title":"Rapid and sensitive liquid chromatography-tandem mass spectrometric method for the quantitative determination of potentially harmful substance 5,5\u2032-oxydimethylenebis(2-furfural) in traditional Chinese medicine injections","volume":"8","author":"Zang","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jpba.2026.117747_bib22","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1208\/s12249-025-03213-5","article-title":"Micro-flow imaging: enhanced precision in clarity assessment of traditional Chinese medicine injections compared to light obscuration and visual inspection","volume":"26","author":"Yang","year":"2025","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jpba.2026.117747_bib23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3390\/molecules21010051","article-title":"Chemical analysis of the herbal medicine Salviae miltiorrhizae Radix et Rhizoma (Danshen)","volume":"21","author":"Pang","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.jpba.2026.117747_bib24","doi-asserted-by":"crossref","first-page":"23801","DOI":"10.1039\/D0RA03172K","article-title":"A novel critical control point and chemical marker identification method for the multi-step process control of herbal medicines via NMR spectroscopy and chemometrics","volume":"10","author":"Zhao","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.jpba.2026.117747_bib25","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/jpp\/rgac034","article-title":"Development of a comprehensive method based on quantitative \u00b9H NMR for quality evaluation of Traditional Chinese Medicine injection: a case study of Danshen Injection","volume":"74","author":"Li","year":"2022","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jpba.2026.117747_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115793","article-title":"Pharmaceutical process-omics for quality control of traditional Chinese medicine preparations: a \u00b9H-qNMR assisted case study of Guanxinning injection","volume":"238","author":"Yang","year":"2024","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117747_bib27","first-page":"163","article-title":"Salvia miltiorrhiza: traditional medicinal uses, chemistry, and pharmacology","volume":"13","author":"Su","year":"2015","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.jpba.2026.117747_bib28","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1002\/rcm.5003","article-title":"Identification of multiple components in Guanxinning injection using hydrophilic interaction liquid chromatography\/time-of-flight mass spectrometry and reversed-phase liquid chromatography\/time-of-flight mass spectrometry","volume":"25","author":"Chen","year":"2011","journal-title":"Rapid Commun. Mass. Spectrom."},{"key":"10.1016\/j.jpba.2026.117747_bib29","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.3109\/13880209.2011.576346","article-title":"Ligusticum chuanxiong Hort: a review of chemistry and pharmacology","volume":"49","author":"Ran","year":"2011","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.jpba.2026.117747_bib30","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jpba.2018.08.027","article-title":"A rapid, simple, and high-throughput UPLC-MS\/MS method for simultaneous determination of bioactive constituents in Salvia miltiorrhiza with positive\/negative ionization switching","volume":"161","author":"Lin","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117747_bib31","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jpba.2014.07.007","article-title":"Comparative analysis of main aromatic acids and phthalides in Angelicae Sinensis Radix, Chuanxiong Rhizoma, and Fo-Shou-San by a validated UHPLC-TQ-MS\/MS","volume":"99","author":"Li","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117747_bib32","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jpba.2017.01.024","article-title":"Rapid determination of 30 bioactive constituents in XueBiJing injection using ultra high performance liquid chromatography-high resolution hybrid quadrupole-Orbitrap mass spectrometry coupled with principal component analysis","volume":"137","author":"Zuo","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117747_bib33","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1021\/es5002105","article-title":"Identifying small molecules via high resolution mass spectrometry: communicating confidence","volume":"48","author":"Schymanski","year":"2014","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.jpba.2026.117747_bib34","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11306-007-0082-2","article-title":"Proposed minimum reporting standards for chemical analysis","volume":"3","author":"Sumner","year":"2007","journal-title":"Metabolomics"},{"key":"10.1016\/j.jpba.2026.117747_bib35","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1021\/ac051437y","article-title":"XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification","volume":"78","author":"Smith","year":"2006","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2026.117747_bib36","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3390\/metabo9070123","article-title":"NMR spectroscopy for metabolomics research","volume":"9","author":"Emwas","year":"2019","journal-title":"Metabolites"},{"key":"10.1016\/j.jpba.2026.117747_bib37","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1002\/rcm.2447","article-title":"Characterization of tanshinones in the roots of Salvia miltiorrhiza (Dan-shen) by high-performance liquid chromatography with electrospray ionization tandem mass spectrometry","volume":"20","author":"Yang","year":"2006","journal-title":"Rapid Commun. Mass. Spectrom."},{"key":"10.1016\/j.jpba.2026.117747_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.964744","article-title":"Rapid quantification of bioactive compounds in Salvia miltiorrhiza Bunge derived decoction pieces, dripping pill, injection, and tablets by polarity-switching UPLC-MS\/MS","volume":"10","author":"Shen","year":"2022","journal-title":"Front. Chem."},{"key":"10.1016\/j.jpba.2026.117747_bib39","doi-asserted-by":"crossref","first-page":"8714","DOI":"10.1039\/C8RA10100K","article-title":"Hybrid multidimensional data acquisition and data processing strategy for comprehensive characterization of known, unknown and isomeric compounds from the compound Dan Zhi Tablet by UPLC\u2011TWIMS\u2011QTOFMS","volume":"9","author":"Cheng","year":"2019","journal-title":"RSC Adv."},{"key":"10.1016\/j.jpba.2026.117747_bib40","doi-asserted-by":"crossref","first-page":"32778","DOI":"10.1039\/D3RA04419J","article-title":"Identification of chemical components and rat serum metabolites in Danggui Buxue decoction based on UPLC\u2011Q\u2011TOF\u2011MS, the UNIFI platform and molecular networks","volume":"13","author":"Lv","year":"2023","journal-title":"RSC Adv."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708526004152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708526004152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T21:26:36Z","timestamp":1793309196000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708526004152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":40,"alternative-id":["S0731708526004152"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2026.117747","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An integrated analytical workflow for characterizing insoluble matter in traditional Chinese medicine injections: Danshen and Guanxinning injections as case studies","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2026.117747","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117747"}}